However, other studies have shown that IL-17A may suppress tumor growth by increasing the infiltration of anti-tumor mast cells and natural killer cells while lowering the infiltration of pro-tumoral M2 macrophages (Figure 1). The gene discussed is IL17A; the disease is neoplasm.